European Medicines Agency's new rules on handling of declared interests of employees

Langues disponibles : en

Documents connexes

  • Affaire : 0642/2012/TN
  • Affaire : 0642/2012/TN
    Ouvert le 23 avr. 2012
  • Institution(s) concernée(s) : Agence européenne des médicaments
  • Domaine(s) juridique : Questions générales, financières et institutionnelles
  • Allégations de mauvaise administration - i) violation de, ou ii) violation des obligations liées à : Légitimité (application incorrecte des règles concernant le fond ou la procédure) [Article 4 CEBCA],Proportionnalité [Article 6 CEBCA]
  • Sujet(s) : Administration et statut des fonctionnaires

Allegation(s)

EMA wrongly requested the complainant to sell her shares in a pharmaceutical company.

Claim(s)

1) EMA sought to apply the new conflict of interest rules before these rules entered into force (in February 2012);

2) EMA's request to her was wrong because no provision of the new conflict of interest rules indicate that these new rules apply to existing staff that obtained shares before the entry into force of the new rules;

3) The new conflict of interest rules are discriminatory against one type of declared interest (shareholdings) when compared with other types of declared interests (previous employment and spouse's employment);

4) The new conflict of interest rules are excessive and disproportionate (she states that EMA's request would cause her substantial financial loss);

5) If she sold the shares in question she  could be considered to be engaged in insider trading; and

6) The new conflict of interest rules constitute a retroactive change to her employment agreement.